We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 40

Antitrust, Competition and Economic Regulation Quarterly Newsletter

  • Hogan Lovells
  • -
  • Africa, China, European Union, Poland, United Kingdom, USA
  • -
  • April 29 2013

On 27 March 2013, the European Commission published for consultation new proposals to simplify and limit the burden associated with merger control

Criminal and related antitrust developments in 2012: Canada and the world

  • Fasken Martineau DuMoulin LLP
  • -
  • Australia, Canada, China, European Union, India, Japan, New Zealand, South Korea, United Kingdom, USA
  • -
  • April 2 2013

This article outlines the major global criminal and related antitrust developments in 2012, with a focus on Canada. Three salient realities

Does it ever make sense for foreign companies to “roll the dice” in an antitrust case?

  • Steptoe & Johnson LLP
  • -
  • China, USA
  • -
  • March 27 2013

On March 14, a jury sitting in the US District Court for the Eastern District of New York found that Chinese suppliers of Vitamin C had acted in

Chinese vitamin C producers price-fixing verdict raises questions of comity and conflict with executive branch views

  • Davis Polk & Wardwell LLP
  • -
  • China, USA
  • -
  • March 27 2013

In a case that potentially has important implications for U.S. antitrust enforcement and for U.S. trade relations with the People's Republic of China

Jury rejects Chinese vitamin C maker’s foreign compulsion defense

  • Cadwalader Wickersham & Taft LLP
  • -
  • China, USA
  • -
  • March 15 2013

A jury has returned a verdict against vitamin C manufacturer Hebei Welcome Pharmaceutical and its parent, North China Pharmaceutical Group, for

Vitamin C makers seek boost from former Chinese official in price-fixing trial

  • Constantine Cannon LLP
  • -
  • China, USA
  • -
  • March 13 2013

Vitamin C manufacturers currently on trial in federal court in Brooklyn are hoping their defense to price-fixing claims will get a boost from last

Expanding reach of Sherman Act draws criticism

  • Pillsbury Winthrop Shaw Pittman LLP
  • -
  • China, European Union, USA
  • -
  • February 20 2013

A major development in antitrust law over the last 25 years has been the adoption and increased enforcement of antitrust laws by jurisdictions around

Chinese SOE unable to extricate itself from US antitrust litigation against vitamin C exporters

  • Hogan Lovells
  • -
  • China, USA
  • -
  • February 18 2013

On 8 February 2013, a New York federal judge denied a motion by North China Pharmaceutical Group Corp. ("NCPGC") for summary judgment in

China intends to simplify anti-monopoly review procedures in 2013

  • Orrick Herrington & Sutcliffe LLP
  • -
  • China, USA
  • -
  • February 4 2013

Shang Ming, the director of the Anti-Monopoly Bureau at China's Ministry of Commerce (MOFCOM), has announced that the implementation of new rules

China clears mobile security joint venture with behavioral conditions

  • Orrick Herrington & Sutcliffe LLP
  • -
  • China, USA
  • -
  • February 4 2013

On Dec. 6, 2012, China's Ministry of Commerce (MOFCOM) cleared a joint venture between UK semiconductor intellectual property supplier ARM Holdings

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy